STOCK TITAN
  1. Home
  2. Sec-filings
  3. KRMD
  4. [Form 4] KORU Medical Systems, Inc. Insider Trading Activity

Insider group in KORU Medical Systems (KRMD) awarded 3,472 shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Manko Joseph M. Jr. reported acquisition or exercise transactions in this Form 4 filing.

KORU Medical Systems insiders reported a new share award. On March 31, 2026, Horton Capital Partners Fund, L.P., a 10% owner, received a grant of 3,472 shares of KORU Medical Systems common stock at no cost, increasing its indirectly held position to 5,065,970 shares.

The filing also shows a separate direct holding of 500,200 common shares reported by the insider group as of the same date, providing context for their overall ownership stake.

Positive

  • None.

Negative

  • None.
Insider Manko Joseph M. Jr., Horton Capital Management, LLC, Horton Capital Partners, LLC, Horton Capital Partners Fund, L.P.
Role Director, 10% Owner | 10% Owner | 10% Owner | 10% Owner
Type Security Shares Price Value
Grant/Award Common Stock 3,472 $0.00 --
holding Common Stock -- -- --
Holdings After Transaction: Common Stock — 5,065,970 shares (Indirect, By Horton Capital Partners Fund, LP); Common Stock — 500,200 shares (Direct)
Footnotes (1)
  1. See Exhibit 99.1 to this Form 4 for explanation of note (1). See Exhibit 99.1 to this Form 4 for explanation of note (2).
Share grant 3,472 shares Common Stock grant on March 31, 2026
Grant price $0.00 per share Reported transaction price for 3,472-share award
Indirect holdings 5,065,970 shares Total Common Stock held indirectly by Horton Capital Partners Fund after grant
Direct holdings 500,200 shares Common Stock directly held as reported in holding entry
grant/award acquisition financial
"The transaction code description notes a grant, award, or other acquisition."
indirect ownership financial
"Ownership is reported as indirect with nature of ownership by Horton Capital Partners Fund."
ten percent owner financial
"Several reporting persons are identified as a ten percent owner of the issuer."
Common Stock financial
"The security title reported for the transaction is Common Stock."
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Manko Joseph M. Jr.
(Last)(First)(Middle)
1717 ARCH STREET
37TH FLOOR
(Street)
PHILADELPHIA PENNSYLVANIA 19103
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
KORU Medical Systems, Inc. [ KRMD ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirectorX10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
03/31/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
Form filed by One Reporting Person
XForm filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock03/31/2026A3,472A$0(1)5,065,970IBy Horton Capital Partners Fund, LP(2)
Common Stock500,200D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
1. Name and Address of Reporting Person*
Manko Joseph M. Jr.
(Last)(First)(Middle)
1717 ARCH STREET
37TH FLOOR
(Street)
PHILADELPHIA PENNSYLVANIA 19103
(City)(State)(Zip)
UNITED STATES
(Country)
Relationship of Reporting Person(s) to Issuer
XDirectorX10% Owner
Officer (give title below)Other (specify below)
1. Name and Address of Reporting Person*
Horton Capital Management, LLC
(Last)(First)(Middle)
1717 ARCH STREET
37TH FLOOR
(Street)
PHILADELPHIA PENNSYLVANIA 19103
(City)(State)(Zip)
UNITED STATES
(Country)
Relationship of Reporting Person(s) to Issuer
DirectorX10% Owner
Officer (give title below)Other (specify below)
1. Name and Address of Reporting Person*
Horton Capital Partners, LLC
(Last)(First)(Middle)
1717 ARCH STREET
37TH FLOOR
(Street)
PHILADELPHIA PENNSYLVANIA 19103
(City)(State)(Zip)
UNITED STATES
(Country)
Relationship of Reporting Person(s) to Issuer
DirectorX10% Owner
Officer (give title below)Other (specify below)
1. Name and Address of Reporting Person*
Horton Capital Partners Fund, L.P.
(Last)(First)(Middle)
1717 ARCH STREET
37TH FLOOR
(Street)
PHILADELPHIA PENNSYLVANIA 19103
(City)(State)(Zip)
UNITED STATES
(Country)
Relationship of Reporting Person(s) to Issuer
DirectorX10% Owner
Officer (give title below)Other (specify below)
Explanation of Responses:
1. See Exhibit 99.1 to this Form 4 for explanation of note (1).
2. See Exhibit 99.1 to this Form 4 for explanation of note (2).
Remarks:
The filing of this statement shall not be construed as an admission (a) that the person filing this statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this statement, or (b) that this statement is legally required to be filed by such person.
/s/ Joseph M. Manko, Jr.04/01/2026
/s/ Joseph M. Manko, Jr., Managing Member of Horton Capital Management, LLC04/01/2026
/s/ Joseph M. Manko, Jr., Managing Member of Horton Capital Partners, LLC04/01/2026
/s/ Joseph M. Manko, Jr., Managing Member of Horton Capital Partners, LLC, the General Partner of Horton Capital Partners Fund, LP04/01/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did KORU Medical Systems (KRMD) report on this Form 4?

KORU Medical Systems reported that Horton Capital Partners Fund, L.P., a 10% owner, received a grant of 3,472 shares of common stock. The award was recorded at a price of $0.00 per share, indicating a compensation-related or similar non-cash acquisition.

How many KORU Medical Systems (KRMD) shares does Horton Capital Partners Fund now report?

After the March 31, 2026 grant, Horton Capital Partners Fund, L.P. reports indirect ownership of 5,065,970 KORU Medical Systems common shares. This figure includes the newly awarded 3,472 shares and reflects the fund’s total indirect position reported in the filing.

Is the KORU Medical Systems (KRMD) Form 4 transaction a market purchase or a grant?

The Form 4 shows a grant or award acquisition, not a market purchase. The 3,472 shares of KORU Medical Systems common stock were reported with a transaction price of $0.00 per share, consistent with a compensation-style or similar non-cash award to the holder.

What direct shareholding is disclosed for the KORU Medical Systems (KRMD) insider group?

The filing lists a direct holding entry of 500,200 KORU Medical Systems common shares. This direct position is reported separately from the 5,065,970 shares held indirectly through Horton Capital Partners Fund, L.P., giving a fuller picture of total reported ownership.

Who are the reporting persons on the KORU Medical Systems (KRMD) Form 4?

Reporting persons include director and 10% owner Joseph M. Manko Jr., plus Horton Capital Management, LLC, Horton Capital Partners, LLC, and Horton Capital Partners Fund, L.P. Each is identified as a 10% owner, reflecting their significant reported holdings in KORU Medical Systems.